# A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer

> **NCT02005549** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 18 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** bevacizumab [Avastin]
- **DRUG:** docetaxel
- **DRUG:** capecitabine [Xeloda]

## Key facts

- **NCT ID:** NCT02005549
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2014-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02005549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02005549, "A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02005549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*